Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing

Q4 Biochemistry, Genetics and Molecular Biology Genetic Engineering & Biotechnology News Pub Date : 2023-10-01 DOI:10.1089/gen.43.10.21
Gareth John Macdonald
{"title":"Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing","authors":"Gareth John Macdonald","doi":"10.1089/gen.43.10.21","DOIUrl":null,"url":null,"abstract":"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 BioprocessingBiopharma Taps Bioprocessing 4.0 Benefits Start FlowingExperts from Cytiva, Lonza, and Pfizer describe how biopharma is embracing data-driven and software-defined bioprocessing systemsGareth John MacdonaldGareth John MacdonaldSearch for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.21AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:Gareth John Macdonald.Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing.Genetic Engineering & Biotechnology News.Oct 2023.54-56, 58.http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF download","PeriodicalId":50425,"journal":{"name":"Genetic Engineering & Biotechnology News","volume":"111 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic Engineering & Biotechnology News","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/gen.43.10.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Genetic Engineering & Biotechnology NewsVol. 43, No. 10 BioprocessingBiopharma Taps Bioprocessing 4.0 Benefits Start FlowingExperts from Cytiva, Lonza, and Pfizer describe how biopharma is embracing data-driven and software-defined bioprocessing systemsGareth John MacdonaldGareth John MacdonaldSearch for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.21AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:Gareth John Macdonald.Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing.Genetic Engineering & Biotechnology News.Oct 2023.54-56, 58.http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF download
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生物制药迎来生物加工4.0时代
基因工程与生物技术新闻卷。43、No. 10生物加工生物制药利用生物加工4.0效益开始流动Cytiva, Lonza,和辉瑞公司描述了生物制药如何拥抱数据驱动和软件定义的生物处理系统加雷斯·约翰·麦克唐纳加雷斯·约翰·麦克唐纳搜索本文作者的更多论文发表在线:2023年10月13日https://doi.org/10.1089/gen.43.10.21AboutSectionsView文章查看全文pdf /EPUB权限和引文spermissions下载引文strack引文添加到收藏回到出版物共享分享在facebook上推特链接在redditemail查看文章figuresreferencesrelateddetails卷信息来源:GEN publishing©2023本文作者:Gareth John Macdonald。生物制药迎来生物加工4.0时代。基因工程与生物技术新闻。2023.54- 56,58 .http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF下载
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物
CiteScore
0.20
自引率
0.00%
发文量
210
审稿时长
3-6 weeks
期刊介绍: Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.
期刊最新文献
Organoids Deliver True-to-Life Performances CRISPR-Edited Silkworms Spin Spider Silk Tougher Than Kevlar Multiomics in Pancreatic Cancer: A Conversation with Dr. William Hwang The Future of Personalized Medicine: Leveraging Customization for Faster Insights NGS Sample Prep: Enduring Basics and Evolving Enzyme Kits
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1